Conference Abstracts : [6734]
Collection home page

Abstracts for conference papers, posters, or presentations.

Browse
in this collection
Subscribe to this collection to receive daily e-mail notification of new additions RSS Feed RSS Feed RSS Feed
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 6734
 next >
PreviewIssue DateTitleAuthor(s)
23-Apr-2026Circulating tumor DNA (ctDNA) analysis guiding adjuvant therapy in patients (pts) with colorectal cancer (CRC): Impact on fear of cancer recurrence (FCR).McLachlan S.-A.; Mostafa R.; Sharpe L.; Burge M.E.; Day F.; Blum R.h.; Campbell R.; Lynam J.F.; Lee B.; Singh M.S.; Lee M.; Chantrill L.A.; Lundy J.; Wong Z.W.; Wong R.; Joshi S.; Saqib A.; Karikios D.J.; Gibbs P.; Tie J.
23-Apr-2026IBI354 (anti-HER2 antibody-drug conjugate [ADC]) in patients (pts) with HER2-positive breast cancer (BC) and other solid tumors: Updates from a phase 1 study.Lemech C.R.; Sun Y.; Nagrial A.; Wu X.; Morris M.F.; Ning F.; Yang J. ; Pan Y.; Cai J.; Lu P.; Zhang T.; Qiu F.; Hu C.; Zhang M.; Liu Z.; Han G.; Nie J.; Teng C.; Zhou H.; Day D. 
28-Apr-2026Embedding imaging within emergency: A satellite model for enhanced patient-centred care.Ardley N.
28-Apr-2026Constructing a collaborative education culture: First-year achievements of a radiology education team.Monsour L.
28-Apr-2026Stitching the abdomen: Can abdominal X-ray stitching program reduce patient dose?.Yu C.Y.; Mathur N.; Lau K.K.
28-Apr-2026Enhancing safety in intravenous contrast practice: A multi-disciplinary initiative to improve oversight and patient management.Jackson D.
1-Feb-2023Evaluating knowledge of obstructive sleep apnoea (OSA) in adults and children amongst health professionals and the general public in Australia.Khabaz-Saberi S.; Ricciardo P.
1-Sep-2023Autotransplantation - Quackery or Science?Nash L.J.
6-Apr-2026The KRAS G12C inhibitor MK-1084 for KRAS G12C-mutated advanced colorectal cancer (CRC): Results from KANDLELIT-001.Lugowska I.A.; Simonelli M.; Xue J.; Sacher A.G.; Stathis A.; Dziadziuszko R.; Park J.O.; Moreno V.; Yeh Y.-M.; Sendur M.A.N.; Su H.Y.-L.; Caglevic C.; Xu R.-H.; Perets R.; Ahern E.S.; Pal A.; Jemielita T.; Molife L.R.; Choi Y.S.; Rojas C.
9-Apr-2026Effects of a multi-modal resistance and impact exercise program on knee cartilage structure, cartilage defects and bone marrow lesions in older adults-An 18-month randomised controlled trial.Daly R. ; Wang Y.; Bailey C.; Nowson C.; Cicuttini F.; Hill K.; Sanders K.; Gianoudis J.; Ebeling P. 
9-Apr-2026Symptomatic and preventive medication use in communitydwelling older people with and without Alzheimer's disease.Liau S.J.; Bell J.S.; Lin J.; Lalic S.; Tolppanen A.-M.; Hartikainen S.
14-Apr-2026POD1UM-303/INTERAACT2 subgroup analyses and impact of delayed retifanlimab treatment on outcomes in patients with squamous cell carcinoma of the anal canal (SCAC).Fakih M.; Muirhead R.; Scott A.J.; Narang M.; Cohn A.L.; Cruz-Correa M.R.; Gupta M.; Essapen S.; Gilbert D.C.; Kudo T.; Lau D.K.W.; Riesco Martinez M.C.; Zampino M.G.; De La Fouchardiere C.; Harrison J.; Jones M.M.; Tian C.; Takashima A.; Capdevila J.; Rao S.
15-Apr-2026PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUBJECTS WITH R/R PTCL.Shortt J. ; Poligone B.; Ribrag V.; Zinzani P.L.; El-Sharkawi D.; Walewski J.; Prica A.; Wilson L.; Souza S. ; Keer H.; Taylor J.; Marchi E.
15-Apr-2026ZANUBRUTINIB (ZANU) VS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENTNAIVE CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): EXTENDED FOLLOW-UP OF THE SEQUOIA STUDY.Munir T.; Shadman M.; Robak T.; Brown J.R.; Kahl B.; Ghia P.; Giannopoulos K.; Simkovic M.; Osterberg A.; Laurenti L.; Walker P. ; Opat S. ; Ciepluch H.; Greil R.; Hanna M.; Tani M.; Trneny M.; Brander D.M.; Flinn I.W.; Grosicki S.; Verner E.; Tedeschi A.; De Guivert S.; Tumyan G.; Laribi K.; Marco J.A.G.; Li J.; Tian T.; Ramakrishnan V.; Liu Y.; Szeto A.; Paik J.; Cohen A.; Tam C.; Jurczak W.
15-Apr-2026LONG-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB (ZANU) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): FINAL ANALYSIS OF THE MAGNOLIA (BGB-3111-214) TRIAL.Opat S. ; Tedeschi A.; Hu B.; Linton K.; Mckay P.; Leitch S.; Jin J.; Sun M.; Sobieraj-Teague M.; Zinzani P.L.; Browett P.; Thieblemont C.; Marina Liberati A.; Bachy E.; Cavallo F.; Costello R.; Iyengar S.; Marasca R.; Mocikova H.; Kim J.S.; Talaulikar D.; Liang Z.; Xu J.; Tankersley C.; Delarue R.; Co M.; Trotman J.
15-Apr-2026LUSPATERCEPT VERSUS EPOETIN ALFA FOR TREATMENT (TX) OF ANEMIA IN ESA-NAIVE LOWERRISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS (PTS) REQUIRING RBC TRANSFUSIONS: DATA FROM THE PHASE 3 COMMANDS STUDY.Della Porta M.G.; Platzbecker U.; Santini V.; Zeidan A.M.; Fenaux P.; Komrokji R.S.; Shortt J. ; Valacarcel D.; Jonasova A.; Dimicoli-Salazar S.; Soo Tiong I.; Lin C.-C.; Li J.; Zhang J.; Guiseppi A.C.; Kreitz S.; Pozharskaya V.; Keeperman K.L.; Rose S.; Shetty J.K.; Hayati S.; Vodala S.; Degulys A.; Paolini S.; Cluzeau T.; Garcia-Manero G.
15-Apr-2026ENCOURAGING COMPLETE RESPONSES (CRS) OBSERVED WITH CDK9 INHIBITOR AZD4573 IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL): EARLY TRIAL ANALYSIS.Shortt J. ; Feldman T.; Collins G.; Zain J.; Khot A.; Kim J.S.; Morschhauser F.; Kim T.M.; Roderick J.; Yoon J.L.; Sharma S. ; Saeh J.; Dai J.; Reyes R.; Olsson R.; Zinzani P.L.
15-Apr-2026RATIONALLY DESIGNED CHIMERIC PI3K-BET BROMODOMAIN INHIBITORS ELICIT CURATIVE RESPONSES IN MYC-DRIVEN LYMPHOMA.Oh D.H.; Ma X.; He J.; Kearney C.; Hogg S.J.; Newbold A.; Fraser P.; Jennings I.G.; Brasacchio D.; Susanto O.; Yew Fong C.; Dawson M.A.; Gruber E.; Kats L.; Johnstone R.W.; Thompson P.E.; Shortt J. 
15-Apr-2026WHAT IS A MASSIVE TRANSFUSION? A SCOPING REVIEW TO INFORM AN INTERNATIONAL CONSENSUS DEFINITION.Lin V.; Sun E.; Yau S.; Abeyakoon C.; Seamer G.; Bhopal S.; Tucker H.; Doree C.; Brunskill S.; Mcquilten Z. ; Stanworth S.J.; Wood E.; Green L.
15-Apr-2026T CELL CD62L EXPRESSION FOLLOWING NIVOLUMAB THERAPY IS ASSOCIATED WITH LONG TERM RESPONSE TO RITUXIMAB-NIVOLUMAB IN TREATMENT NAIVE FOLLICULAR LYMPHOMA: RESULTS FROM THE 1ST FLOR STUDY.Koldej R.; Barraclough A.; Lee S.T.; Morgan H.; Holzwart N.; Koshy M.; Smith C.; Chong G.; Gilbertson M. ; Keane C.; Ting S.; Churilov L.; Ritchie D.; Hawkes E.A.
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 6734
 next >

Date issued